 |
| Jack Leslie |
Jack Leslie, former chairman of Weber Shandwick, has joined Duke University as a senior visiting fellow at the Duke Global Health Institute and the Duke-Margolis Center for Health Policy.
His role is to develop an inititiave to increase trust in public health, which suffered a big hit during the COVID-19 pandemic.
“Jack has been a pioneer in bringing a broad base of stakeholders together to work to solve leading, complex health challenges. His passionate commitment to health equity, demonstrated through his years of public and private sector contributions on this consequential issue, will inform his valuable contributions to Duke and this initiative to advance public health locally, nationally, and globally,” Mark McClellan, founding director of the Margolis Center, said in a statement.
Leslie noted that trust in public health has been significantly undermined during the COVID-19 pandemic. He called DGHI and the Margolis Center leaders in global health and health policy that can harness the resources and talent needed to address this important issue.
President Obama appointed Leslie, who was legislative aide to Sen. Ted Kennedy, chair of the U.S. African Development Foundation in 2009. Leslie also chairs the board of the Elizabeth Glaser Pediatric AIDS Foundation.
The nearly 40-year veteran of Weber Shandwick, remains a senior advisor at the Interpublic unit.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
